SINGH, Charanpreet et al. High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings. Acta Oncologica, [S. l.], v. 61, n. 12, p. 1512–1514, 2022. DOI: 10.1080/0284186X.2022.2162347. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/23787. Acesso em: 20 jun. 2026.